Clinical Trial Update: N-of-1 Trial: Actionable Target Identification in Metastatic Cancer for Palliative Systemic Therapy [Phase 2]

View source ↗

Summary

Phase 2 N-of-1 trial focused on actionable target identification in metastatic cancer for guiding palliative systemic therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: Oslo University Hospital | Conditions: Metastatic Cancer | Phase 2 | Status: COMPLETED